India Rupee Decline Upsets MNC Plans, Delays Some Drug Launches
This article was originally published in PharmAsia News
Executive Summary
The nine-month fall in the value of India's rupee against foreign currencies has begun to have an adverse impact on Novo Nordisk and other multinational drug makers doing business in the country.